» Articles » PMID: 25534317

Gamma-linolenic Acid Inhibits Hepatic PAI-1 Expression by Inhibiting P38 MAPK-dependent Activator Protein and Mitochondria-mediated Apoptosis Pathway

Overview
Journal Apoptosis
Publisher Springer
Date 2014 Dec 24
PMID 25534317
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Fibrosis is induced by the excessive and abnormal deposition of extracellular matrix (ECM) with various growth factors in tissues. Transforming growth factor beta 1 (TGF-β1), plays a role in inducing apoptosis, modulates fibrosis, and ECM accumulation. Plasminogen activator inhibitor 1 (PAI-1) plays an important role in the development hepatic fibrosis. The overexpression of PAI-1 induces ECM accumulation, the main hallmark of chronic liver diseases. Death of hepatocytes is a characteristic feature of chronic liver disease due to various causes. The TGF-β1-mediated apoptotic pathway is regarded as a promising therapeutic target in hepatic fibrosis. Gamma-linolenic acid (GLA) is of special interest as it possesses anti-fibrosis, anti-inflammatory, and anti-cancer properties. However, the precise mechanism for GLA in chronic liver disease is not still clear. The aim of the present study was to determine whether GLA prevents hepatic PAI-1 expression and apoptosis through the inhibition of TGF-β1-mediated molecular mediators. GLA attenuated TGF-β1-stimulated PAI-1 expression, and inhibited PAI-1 promoter activity in AML12 cells. This effect was mediated by Smad3/4, the p38 pathways. We also found that GLA suppressed TGF-β1-induced apoptotic activation of the Bcl-2 family and caspase family of proteins, which resulted in the inhibition of poly-ADP-ribose polymerase 1 cleavage. GLA ameliorates the pro-fibrotic and pro-apoptotic effects of TGF-β1 in hepatocytes, suggesting GLA exerts a protective effect on hepatocytes and has a therapeutic potential for the treatment of chronic liver disease.

Citing Articles

The Landscape of Using Glycosyltransferase Gene Signatures for Overall Survival Prediction in Hepatocellular Carcinoma.

Cai Q, Yu S, Zhao J, Ma D, Jiang L, Zhang X J Oncol. 2022; 2022:5989419.

PMID: 35774357 PMC: 9239767. DOI: 10.1155/2022/5989419.


Pomolic Acid Ameliorates Fibroblast Activation and Renal Interstitial Fibrosis through Inhibition of SMAD-STAT Signaling Pathways.

Park J, Jang K, An H, Kim J, Gwon M, Gu H Molecules. 2018; 23(9).

PMID: 30177595 PMC: 6225234. DOI: 10.3390/molecules23092236.


Asiatic acid attenuates methamphetamine-induced neuroinflammation and neurotoxicity through blocking of NF-kB/STAT3/ERK and mitochondria-mediated apoptosis pathway.

Park J, Seo Y, Jang J, Jeong C, Lee S, Park B J Neuroinflammation. 2017; 14(1):240.

PMID: 29228978 PMC: 5725763. DOI: 10.1186/s12974-017-1009-0.


Suppression of Hepatic Epithelial-to-Mesenchymal Transition by Melittin via Blocking of TGFβ/Smad and MAPK-JNK Signaling Pathways.

Park J, Park B, Park K Toxins (Basel). 2017; 9(4).

PMID: 28406452 PMC: 5408212. DOI: 10.3390/toxins9040138.